Stockscreener 앱 받기
37.13
2.70%
-1.03
시간 외 거래:
37.13
전일 마감가:
$38.16
열려 있는:
$38.26
하루 거래량:
386.86K
Relative Volume:
0.46
시가총액:
$1.71B
수익:
-
순이익/손실:
$-146.66M
주가수익비율:
-13.48
EPS:
-2.7541
순현금흐름:
$-133.21M
1주 성능:
+1.39%
1개월 성능:
-0.30%
6개월 성능:
+22.26%
1년 성능:
-20.92%
1일 변동 폭
$36.68
$38.37
1주일 범위
$35.68
$38.75
52주 변동 폭
$26.20
$63.50
Apogee Therapeutics Inc Stock (APGE) Company Profile
명칭
Apogee Therapeutics Inc
전화
650-394-5230
주소
221 CRESCENT ST., WALTHAM
APGE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
37.13 | 2.26B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 재확인 | BTIG Research | Buy |
| 2025-03-13 | 개시 | Citigroup | Buy |
| 2024-11-25 | 개시 | Canaccord Genuity | Buy |
| 2024-05-10 | 개시 | BofA Securities | Buy |
| 2023-12-20 | 개시 | BTIG Research | Buy |
| 2023-08-08 | 개시 | Guggenheim | Buy |
| 2023-08-08 | 개시 | Jefferies | Buy |
| 2023-08-08 | 개시 | Stifel | Buy |
| 2023-08-08 | 개시 | TD Cowen | Outperform |
| 2023-08-08 | 개시 | Wedbush | Outperform |
모두보기
Apogee Therapeutics Inc 주식(APGE)의 최신 뉴스
Can technical indicators confirm Apogee Therapeutics Inc.’s reversalQuarterly Profit Summary & Smart Allocation Stock Reports - Newser
Using data models to predict Apogee Therapeutics Inc. stock movementQuarterly Portfolio Report & Trade Opportunity Analysis - Newser
Technical analysis overview for Apogee Therapeutics Inc. stockCEO Change & Weekly Market Pulse Updates - Newser
Apogee Therapeutics to Participate at the Stifel 2025 Virtual Immunology and Inflammation Forum - The Manila Times
Apogee Therapeutics to Participate in Stifel Virtual Immunology Forum. - AInvest
Apogee Therapeutics to Present at Stifel 2025 Virtual Immunology and Inflammation Forum - AInvest
Biotech Innovator Apogee Therapeutics Featured at Upcoming Stifel 2025 Immunology Conference - Stock Titan
Long term hold vs stop loss in Apogee Therapeutics Inc.Chart Signals & Weekly High Return Stock Opportunities - Newser
Using R and stats models for Apogee Therapeutics Inc. forecastingJuly 2025 Levels & Real-Time Chart Breakout Alerts - Newser
Institutional scanner results for Apogee Therapeutics Inc.Trade Entry Summary & Technical Pattern Alert System - Newser
Volume spikes in Apogee Therapeutics Inc. stock – what they meanTrade Analysis Summary & Safe Capital Growth Trade Ideas - Newser
Real time pattern detection on Apogee Therapeutics Inc. stock2025 Trading Recap & Technical Entry and Exit Alerts - Newser
Will Apogee Therapeutics Inc. bounce back from current supportWeekly Profit Report & Fast Moving Stock Watchlists - Newser
Risk adjusted return profile for Apogee Therapeutics Inc. analyzedTrade Signal Summary & Risk Managed Investment Strategies - Newser
Apogee Therapeutics Inc. stock daily chart insightsWeekly Trade Review & Reliable Trade Execution Plans - Newser
What technical models suggest about Apogee Therapeutics Inc.’s comeback - Newser
Will Apogee Therapeutics Inc. rebound enough to break evenChart Signals & High Conviction Buy Zone Picks - Newser
Relative strength of Apogee Therapeutics Inc. in sector analysis2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - Newser
Comparing Apogee Therapeutics Inc. in custom built stock radars2025 AllTime Highs & Detailed Earnings Play Strategies - Newser
Advanced analytics toolkit walkthrough for Apogee Therapeutics Inc.Quarterly Portfolio Report & Advanced Swing Trade Entry Plans - Newser
Apogee Therapeutics Inc. stock momentum explained2025 Price Action Summary & Step-by-Step Trade Execution Guides - Newser
Analyzing recovery setups for Apogee Therapeutics Inc. investorsJuly 2025 Highlights & Real-Time Buy Signal Notifications - Newser
Visual analytics tools that track Apogee Therapeutics Inc. performanceJuly 2025 Breakouts & Weekly High Potential Stock Alerts - Newser
Does Apogee Therapeutics Inc. have a sustainable dividendTrend Reversal & Smart Allocation Stock Reports - khodrobank.com
Is Apogee Therapeutics Inc. Forming a Bottom Pattern getLinesFromResByArray error: size == 0 - kangso.co.kr
Is Apogee Therapeutics Inc. stock overvalued or fairly priced2025 Trading Recap & Stepwise Trade Signal Implementation - khodrobank.com
When is the best time to exit Apogee Therapeutics Inc.July 2025 Update & Short-Term Trading Opportunity Alerts - Newser
Why Apogee Therapeutics Inc. is moving today2025 Growth vs Value & Low Risk Profit Maximizing Plans - Newser
Will Apogee Therapeutics Inc. benefit from geopolitical trends2025 Year in Review & Real-Time Buy Signal Alerts - khodrobank.com
Exit strategy if you’re trapped in Apogee Therapeutics Inc.Portfolio Update Summary & Reliable Intraday Trade Plans - Newser
Can Apogee Therapeutics Inc. hit a new high this monthWeekly Gains Report & Expert Approved Trade Ideas - Newser
Smart tools for monitoring Apogee Therapeutics Inc.’s price actionJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - Newser
Is Apogee Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Risk Summary & Reliable Volume Spike Trade Alerts - Newser
Understanding Apogee Therapeutics Inc.’s price movement2025 Top Decliners & Technical Pattern Recognition Alerts - Newser
Apogee Therapeutics Inc. Builds Base for Possible Rebound getLinesFromResByArray error: size == 0 - 클래시안
Apogee Therapeutics Inc. stock trend forecastJuly 2025 Fed Impact & AI Based Buy and Sell Signals - Newser
Apogee Therapeutics Inc (APGE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Apogee Therapeutics Inc 주식 (APGE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Dambkowski Carl | Chief Medical Officer |
Jul 02 '25 |
Option Exercise |
22.86 |
7,365 |
168,364 |
249,088 |
| Dambkowski Carl | Chief Medical Officer |
Jul 02 '25 |
Sale |
45.09 |
10,090 |
454,954 |
238,998 |
1.75%
1.11%
자본화:
|
볼륨(24시간):